• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金橘素作为癌症靶点/通路调节剂的前景。

Prospects of tangeretin as a modulator of cancer targets/pathways.

机构信息

Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, 226015, Uttar Pradesh, India; Jawaharlal Nehru University, New Delhi, 110067, India.

Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, 226015, Uttar Pradesh, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, Uttar Pradesh, India.

出版信息

Pharmacol Res. 2020 Nov;161:105202. doi: 10.1016/j.phrs.2020.105202. Epub 2020 Sep 15.

DOI:10.1016/j.phrs.2020.105202
PMID:32942013
Abstract

To date, cancer is the second leading cause of death worldwide after cardiac arrest. A large number of synthetic drugs are available for the treatment of different types of cancer; however, a major problem associated with these drugs is its toxicity towards the normal cells. To overcome these problems, researchers explore plants derived phytochemicals because of their pleiotropic action and least toxicity towards the normal cells. Tangeretin is a polymethoxylated flavone found extensively in citrus fruits and has shown potent anti-cancer activity in different types of cancer cells. Hence, this review examines the anti-cancer activity of tangeretin via different molecular targets/pathways. Tangeretin induces apoptosis via intrinsic as well as extrinsic pathways and arrest the cell cycle. It also suppresses cell proliferation by modulating PI3K/AKT/mTOR, Notch, and MAPK signalling pathways. Besides, it induces autophagic cell death, suppresses migration, invasion, and angiogenesis. Further, the role of tangeretin in multi-drug resistance and combination therapy, different biological sources of tangeretin, its derivatives, and pharmacokinetics profile and toxicity studies are also discussed. Towards the end, the challenges associated with tangeretin usage as potential anti-cancer phytochemicals have also been discussed. Tangeretin, like a pandora's box, needs to be explored further, and more research is warranted to improve its usefulness for better human health.

摘要

迄今为止,癌症是全球仅次于心脏骤停的第二大死亡原因。有大量的合成药物可用于治疗不同类型的癌症;然而,这些药物的一个主要问题是它们对正常细胞的毒性。为了克服这些问题,研究人员探索了植物来源的植物化学物质,因为它们具有多效性作用,对正常细胞的毒性最小。橘红素是一种广泛存在于柑橘类水果中的多甲氧基黄酮,已显示出对不同类型癌细胞的强大抗癌活性。因此,本综述通过不同的分子靶点/途径检查了橘红素的抗癌活性。橘红素通过内在和外在途径诱导细胞凋亡,并阻止细胞周期。它还通过调节 PI3K/AKT/mTOR、Notch 和 MAPK 信号通路来抑制细胞增殖。此外,它诱导自噬性细胞死亡、抑制迁移、侵袭和血管生成。此外,还讨论了橘红素在多药耐药和联合治疗中的作用、橘红素的不同生物来源、其衍生物以及药代动力学特征和毒性研究。最后,还讨论了将橘红素用作潜在抗癌植物化学物质的相关挑战。橘红素就像潘多拉的盒子一样,需要进一步探索,需要更多的研究来提高其对人类健康的有益性。

相似文献

1
Prospects of tangeretin as a modulator of cancer targets/pathways.金橘素作为癌症靶点/通路调节剂的前景。
Pharmacol Res. 2020 Nov;161:105202. doi: 10.1016/j.phrs.2020.105202. Epub 2020 Sep 15.
2
Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced proliferation and migration of aortic smooth muscle cells by blocking AKT activation.蜜橘素,一种柑橘类黄酮,通过阻断 AKT 激活抑制 PDGF-BB 诱导的主动脉平滑肌细胞增殖和迁移。
Eur J Pharmacol. 2011 Dec 30;673(1-3):56-64. doi: 10.1016/j.ejphar.2011.10.011. Epub 2011 Oct 21.
3
Chemotherapeutic effect of tangeretin, a polymethoxylated flavone studied in 7, 12-dimethylbenz(a)anthracene induced mammary carcinoma in experimental rats.在实验大鼠的 7,12-二甲基苯并(a)蒽诱导的乳腺癌中研究的多甲氧基黄酮蜜橘素的化疗效果。
Biochimie. 2014 Apr;99:96-109. doi: 10.1016/j.biochi.2013.11.017. Epub 2013 Dec 1.
4
Tangeretin as an adjuvant and chemotherapeutic sensitizer against various types of cancers: a comparative overview.使用辅舒柠作为针对各种癌症的辅助治疗和化疗增敏剂:比较综述。
J Pharm Pharmacol. 2021 Mar 27;73(5):601-610. doi: 10.1093/jpp/rgab013.
5
Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells.柑橘中多甲氧基黄酮对人神经母细胞瘤SH-SY5Y细胞生长抑制的交互作用。
Bioorg Med Chem. 2008 Mar 15;16(6):2803-10. doi: 10.1016/j.bmc.2008.01.058. Epub 2008 Feb 5.
6
Tangeretin boosts the anticancer activity of metformin in breast cancer cells via curbing the energy production.陈皮素通过抑制能量产生增强二甲双胍在乳腺癌细胞中的抗癌活性。
Phytomedicine. 2021 Mar;83:153470. doi: 10.1016/j.phymed.2021.153470. Epub 2021 Jan 17.
7
Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function.橘红素,一种源自柑橘的五甲氧基黄酮,通过抑制 ABCB1 的转运功能来拮抗 ABCB1 介导的多药耐药性。
Pharmacol Res. 2016 Aug;110:193-204. doi: 10.1016/j.phrs.2016.04.003. Epub 2016 Apr 4.
8
Inhibitory Effects of Tangeretin, A Citrus Peel-Derived Flavonoid, on Breast Cancer Stem Cell Formation through Suppression of Stat3 Signaling.蜜橘素,一种源自柑橘皮的类黄酮,通过抑制 Stat3 信号通路抑制乳腺癌干细胞的形成。
Molecules. 2020 Jun 3;25(11):2599. doi: 10.3390/molecules25112599.
9
Inhibition of cancer cell growth by Tangeretin flavone in drug-resistant MDA-MB-231 human breast carcinoma cells is facilitated via targeting cell apoptosis, cell cycle phase distribution, cell invasion and activation of numerous Caspases.橘皮素黄酮通过靶向细胞凋亡、细胞周期阶段分布、细胞侵袭以及多种半胱天冬酶的激活,促进其对耐药性人MDA-MB-231乳腺癌细胞的癌细胞生长抑制作用。
J BUON. 2019 Jul-Aug;24(4):1532-1537.
10
Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells.陈皮素通过抑制人肺癌细胞中p38丝裂原活化蛋白激酶(MAPK)、应激活化蛋白激酶(JNK)和蛋白激酶B(AKT)的激活来抑制白细胞介素-1β(IL-1β)诱导的环氧化酶(COX)-2表达。
Biochem Pharmacol. 2007 Jan 15;73(2):215-27. doi: 10.1016/j.bcp.2006.09.018. Epub 2006 Sep 22.

引用本文的文献

1
Harnessing Natural Products to Surmount Drug Resistance in Gastric Cancer: Mechanisms and Therapeutic Perspectives.利用天然产物克服胃癌耐药性:机制与治疗前景
Int J Biol Sci. 2025 Jul 11;21(10):4604-4628. doi: 10.7150/ijbs.113709. eCollection 2025.
2
Identification of key targets and exploration of therapeutic molecular mechanisms of natural compound tangeretin in osteosarcoma.天然化合物陈皮素在骨肉瘤中的关键靶点鉴定及治疗分子机制探索
Discov Oncol. 2025 Jul 24;16(1):1401. doi: 10.1007/s12672-025-03221-8.
3
Microplastics as Emerging Contaminants and Human Health: Exploring Functional Nutrition in Gastric-Colon-Brain Axis Cancer.
微塑料作为新兴污染物与人类健康:探索胃-结肠-脑轴癌症中的功能性营养
Toxics. 2025 May 26;13(6):438. doi: 10.3390/toxics13060438.
4
Tangeretin suppresses RANKL-induced osteoclastogenesis and alleviates postmenopausal osteoporosis by inhibiting Notch signaling.陈皮素通过抑制Notch信号通路抑制RANKL诱导的破骨细胞生成并减轻绝经后骨质疏松症。
Regen Ther. 2025 Jun 7;30:136-143. doi: 10.1016/j.reth.2025.04.019. eCollection 2025 Dec.
5
Chemotherapy cardiotoxicity research in cancer patients: a bibliometric and visual analysis (1994-2024).癌症患者化疗心脏毒性研究:文献计量与可视化分析(1994 - 2024年)
Front Oncol. 2025 May 15;15:1502361. doi: 10.3389/fonc.2025.1502361. eCollection 2025.
6
Tangeretin Improves the Memory of Swiss Mice, Suggesting Potential Molecular Interventions Through Animal Behavior Assessments and In Silico Studies.陈皮素改善瑞士小鼠的记忆,通过动物行为评估和计算机模拟研究揭示潜在的分子干预作用。
Brain Behav. 2025 May;15(5):e70516. doi: 10.1002/brb3.70516.
7
Elucidation of the mechanism Underlying the promotion of ferroptosis and enhanced antitumor immunity by citrus polymethoxyflavones in CRC cells.阐明柑橘多甲氧基黄酮在结直肠癌细胞中促进铁死亡和增强抗肿瘤免疫的潜在机制。
Front Pharmacol. 2025 Apr 11;16:1571178. doi: 10.3389/fphar.2025.1571178. eCollection 2025.
8
Phytochemical insights into flavonoids in cancer: Mechanisms, therapeutic potential, and the case of quercetin.癌症中黄酮类化合物的植物化学见解:作用机制、治疗潜力及槲皮素的案例
Heliyon. 2025 Feb 13;11(4):e42682. doi: 10.1016/j.heliyon.2025.e42682. eCollection 2025 Feb 28.
9
Osteoporosis: Causes, Mechanisms, Treatment and Prevention: Role of Dietary Compounds.骨质疏松症:病因、机制、治疗与预防:膳食化合物的作用
Pharmaceuticals (Basel). 2024 Dec 16;17(12):1697. doi: 10.3390/ph17121697.
10
Proteomics-based network pharmacology and molecular docking reveal the potential mechanisms of 5,6,7,4'-tetramethoxyflavone against HeLa cancer cells.基于蛋白质组学的网络药理学和分子对接揭示5,6,7,4'-四甲氧基黄酮抗人宫颈癌HeLa细胞的潜在机制
Heliyon. 2024 Oct 4;10(20):e38951. doi: 10.1016/j.heliyon.2024.e38951. eCollection 2024 Oct 30.